Year archive

CAMBIUM BIO LIMITED — 2017 filings

All 33 regulatory filings released by CAMBIUM BIO LIMITED (CMB) in 2017, sourced directly from the official regulator.

33 Filings

2017 Period

2017 filings (33)

Filing	Released	Lang
Regeneus appoints Japan-based non-executive director 3 pages 816.5KB Board/Management Information	2017-12-10	English
Chairman's Address to Shareholders 3 pages 211.5KB AGM Information	2017-11-01	English
CEO Presentation to 2017 Annual General Meeting 35 pages 4.7MB Investor Presentation	2017-11-01	English
Results of Annual General Meeting 2 pages 866.0KB Regulatory Filings	2017-11-01	English
Presentation on Japan First Strategy at Ord Minnett 21 pages 3.9MB Investor Presentation	2017-10-31	English
Appendix 4C - Quarterly 6 pages 1.2MB Regulatory Filings	2017-10-23	English
Notice of Annual General Meeting / Proxy Form 13 pages 488.5KB AGM Information	2017-09-27	English
Sygenus shows longer lasting effect on pain than morphine 2 pages 262.3KB Regulatory Filings	2017-09-25	English
Date of AGM 1 page 381.0KB Regulatory Filings	2017-09-05	English
Regeneus receives R&D tax incentive refund of $2.6m 1 Capital/Financing Update	2017-08-28	English
Appendix 4E 2 pages 929.8KB Regulatory Filings	2017-08-21	English
Annual Report 2017 52 pages 12.1MB Regulatory Filings	2017-08-21	English
Appendix 4G and Corporate Governance Statement 18 pages 9.4MB Regulatory Filings	2017-08-21	English
FY17 Results Announcement 2 pages 203.3KB Annual Report	2017-08-21	English
FY17 Results Presentation 28 pages 5.3MB Investor Presentation	2017-08-21	English
Appendix 4E Revised 2 pages 927.1KB Regulatory Filings	2017-08-21	English
Appendix 4C - Quarterly 6 pages 1.5MB Regulatory Filings	2017-07-25	English
US patent allowed for Sygenus for acne 2 pages 110.1KB Regulatory Filings	2017-07-09	English
Q2 2017 Update 7 pages 2.0MB Regulatory Filings	2017-07-04	English
RGS to receive milestone payment for successful Phase I 1 Capital/Financing Update	2017-06-20	English
RGS presentation to ChinaBio Partnering Forum 22 pages 1.4MB Investor Presentation	2017-05-30	English
Japanese Patent Office to grant key patent for Progenza 2 pages 112.8KB Regulatory Filings	2017-05-23	English
Positive clinical trial results for Progenza 3 pages 133.1KB Capital/Financing Update	2017-05-21	English
Appendix 4C - Quarterly 6 pages 489.0KB Regulatory Filings	2017-04-23	English
Regeneus joins Austrade's business mission in Japan 2 pages 110.8KB Regulatory Filings	2017-04-17	English
Chinese patent granted on stem cell secretions technology 2 pages 185.2KB Regulatory Filings	2017-03-27	English
Appendix 3Y Change of Director's Interest Notice 2 pages 82.9KB Director's Dealing	2017-03-08	English
Appendix 4D and Half-Year Report 24 pages 676.0KB Interim / Quarterly Report	2017-02-21	English
Half-Year Results Announcement 2 pages 199.3KB Interim / Quarterly Report	2017-02-21	English
Japan Update and Half-Year Results Presentation 15 pages 3.8MB Interim / Quarterly Report	2017-02-21	English
Appendix 4C - Quarterly 6 pages 489.2KB Regulatory Filings	2017-01-30	English
Regeneus receives upfront payment of US$5.5m from AGC 1 Capital/Financing Update	2017-01-22	English
Q4 2016 Update 4 pages 715.0KB Investor Presentation	2017-01-17	English

Filings by year

2026 12 filings
2025 52 filings
2024 24 filings
2023 22 filings
2022 24 filings
2021 43 filings
2020 52 filings
2019 52 filings
2018 33 filings
2017 33 filings
2016 27 filings
2015 37 filings
2014 52 filings
2013 41 filings